Information Security Summit slated for May 24
MassBay Community College and Towerwall will hold the sixth annual Information Security Summit from 7:30 a.m. to 1:30 p.m. May 24 at the MassBay Wellesley Hills campus, 50 Oakland St. Attendees will learn from industry experts as they share their experience and knowledge regarding guiding principles of information security, user awareness, training/social engineering, cloud and security, threats and ransomware, risk management and compliance, enabling the summit participants to connect through the leaders driving innovation in the security sector. This year’s keynote address will be given by Bob Bragdon, senior vice president and publisher of CSO, the leading information resource for security, risk and privacy executives. Bragdon leads all operations for the full CSO product line, including http://CSOonline.com, the CSO portfolio of national and regional events and the Security Smart Newsletter. During his keynote, he will be discussing “Building a secure business: from culture to cloud”. Preregistration is required and a $45 registration fee does apply. To register: https://bit.ly/2FWjoqK. For information: http://massbay.edu/iss.
Great Elm Capital Corp.announce stockholder approval
Great Elm Capital Corp., of Waltham, an externally managed, business development company focused on investing in debt instruments of leveraged middle market issuers, recently announced that a majority of the stockholders of the company approved the application of the modified minimum asset coverage requirements set forth in Section 61(a)(2) of the Investment Company Act of 1940, as amended, in accordance with the Small Business Credit Availability Act (“SBCAA”) that was signed into law on March 23. As a result of such approval, and subject to satisfying certain ongoing disclosure requirements under the SBCAA, effective May 4, the asset coverage ratio test applicable to the Company has been decreased from 200 percent to 150 percent, permitting the company to incur additional leverage.
Technical Communications Corporation announces results
Technical Communications Corporation, of Concord, announced its results for the three and six month periods ended March 31. For the three months ended March 31, the company reported a net loss of $313,000, or $0.17 per share, on revenue of $930,000, compared to net income of $128,000, or $0.07 per share, on revenue of $1,385,000 for the quarter ended April 1, 2017. For the six months ended March 31, the company reported a net loss of $365,000, or $0.20 per share, on revenue of $2,046,000, compared to a net loss of $567,000, or $0.31 per share, on revenue of $2,017,000 for the six months ended April 1, 2017.
Proteon Therapeutics announces contract extension
Proteon Therapeutics, of Waltham, a company developing novel, first-in-class therapeutics to address the medical needs of patients with kidney and vascular diseases, recently announced a long-term contract extension with Lonza Pharma & Biotech for the commercial supply of investigational vonapanitase’s active pharmaceutical ingredient. Lonza has manufactured API for Proteon at its microbial manufacturing facility in Visp since 2009. Initially, a small-scale process was transferred into Lonza’s development labs for process optimization and consistency studies. The process was then scaled up to 1,000L scale cGMP manufacture to support Proteon’s early clinical studies and potential commercial requirements. As Proteon worked to complete enrollment in its ongoing phase three clinical trial, PATENCY-2, Lonza supported Proteon with three process validation batches at 1,000L commercial scale, each of which met the intended release criteria. If PATENCY-2 is successful, Proteon expects to include results from these validation runs in a potential Biologics License Application filing in the second half of 2019, which Lonza will support.
No comments:
Post a Comment